JP Morgan Put 290 AMGN 20.06.2025/ DE000JK6CQS7 /
1/15/2025 12:59:00 PM | Chg.+0.19 | Bid1:15:22 PM | Ask1:15:22 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.13EUR | +6.46% | 3.13 Bid Size: 7,500 |
3.19 Ask Size: 7,500 |
Amgen Inc | 290.00 USD | 6/20/2025 | Put |
GlobeNewswire
8/29/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
8/28/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
8/15/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
8/12/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
8/8/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/8/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
8/5/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
8/1/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024